218 related articles for article (PubMed ID: 25404736)
1. Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.
Katsuyama E; Miyamoto H; Kobayashi T; Sato Y; Hao W; Kanagawa H; Fujie A; Tando T; Watanabe R; Morita M; Miyamoto K; Niki Y; Morioka H; Matsumoto M; Toyama Y; Miyamoto T
J Biol Chem; 2015 Jan; 290(2):716-26. PubMed ID: 25404736
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions.
Oya A; Katsuyama E; Morita M; Sato Y; Kobayashi T; Miyamoto K; Nishiwaki T; Funayama A; Fujita Y; Kobayashi T; Matsumoto M; Nakamura M; Kanaji A; Miyamoto T
J Bone Miner Metab; 2018 Nov; 36(6):679-690. PubMed ID: 29273889
[TBL] [Abstract][Full Text] [Related]
3. IRAK4 inhibition: an effective strategy for immunomodulating peri-implant osseointegration via reciprocally-shifted polarization in the monocyte-macrophage lineage cells.
Zhao J; Li J; Xu A; Xu Y; He F; Mao Y
BMC Oral Health; 2023 May; 23(1):265. PubMed ID: 37158847
[TBL] [Abstract][Full Text] [Related]
4. The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts.
ten Harkel B; Schoenmaker T; Picavet DI; Davison NL; de Vries TJ; Everts V
PLoS One; 2015; 10(10):e0139564. PubMed ID: 26426806
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of chemokines, chemokine receptors and proteinases by foreign body giant cells (FBGCs) and osteoclasts.
Khan UA; Hashimi SM; Khan S; Quan J; Bakr MM; Forwood MR; Morrison NM
J Cell Biochem; 2014 Jul; 115(7):1290-8. PubMed ID: 24500983
[TBL] [Abstract][Full Text] [Related]
6. Cytokine receptor profile of arthroplasty macrophages, foreign body giant cells and mature osteoclasts.
Neale SD; Athanasou NA
Acta Orthop Scand; 1999 Oct; 70(5):452-8. PubMed ID: 10622477
[TBL] [Abstract][Full Text] [Related]
7. Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells.
McNally AK; Anderson JM
Exp Mol Pathol; 2011 Dec; 91(3):673-81. PubMed ID: 21798256
[TBL] [Abstract][Full Text] [Related]
8. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
9. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis
Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J
FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415
[TBL] [Abstract][Full Text] [Related]
10. Modulation of macrophage subtypes by IRF5 determines osteoclastogenic potential.
Yang J; Park OJ; Kim J; Kwon Y; Yun CH; Han SH
J Cell Physiol; 2019 Dec; 234(12):23033-23042. PubMed ID: 31127629
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
[TBL] [Abstract][Full Text] [Related]
12. Loss of protein kinase C-δ protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorption.
Khor EC; Abel T; Tickner J; Chim SM; Wang C; Cheng T; Ng B; Ng PY; Teguh DA; Kenny J; Yang X; Chen H; Nakayama KI; Nakayama K; Pavlos N; Zheng MH; Xu J
PLoS One; 2013; 8(8):e70815. PubMed ID: 23951014
[TBL] [Abstract][Full Text] [Related]
13. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
[TBL] [Abstract][Full Text] [Related]
14. CCL2 and CCR2 are Essential for the Formation of Osteoclasts and Foreign Body Giant Cells.
Khan UA; Hashimi SM; Bakr MM; Forwood MR; Morrison NA
J Cell Biochem; 2016 Feb; 117(2):382-9. PubMed ID: 26205994
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of WKYMVm peptide on inflammatory osteolysis through regulating NF-κB and CD9/gp130/STAT3 signalling pathway.
Hu J; Li X; Chen Y; Han X; Li L; Yang Z; Duan L; Lu H; He Q
J Cell Mol Med; 2020 Jan; 24(2):1893-1905. PubMed ID: 31837208
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of osteoclastogenesis by RNA interference targeting RANK.
Ma R; Xu J; Dong B; Kauther MD; Jäger M; Wedemeyer C
BMC Musculoskelet Disord; 2012 Aug; 13():154. PubMed ID: 22913338
[TBL] [Abstract][Full Text] [Related]
17. Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1.
Kang H; Yan Y; Jia P; Yang K; Guo C; Chen H; Qi J; Qian N; Xu X; Wang F; Li C; Guo L; Deng L
Cell Death Dis; 2016 Oct; 7(10):e2435. PubMed ID: 27787522
[TBL] [Abstract][Full Text] [Related]
18. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
[TBL] [Abstract][Full Text] [Related]
19. Foreign body giant cells and osteoclasts are TRAP positive, have podosome-belts and both require OC-STAMP for cell fusion.
Khan UA; Hashimi SM; Bakr MM; Forwood MR; Morrison NA
J Cell Biochem; 2013 Aug; 114(8):1772-8. PubMed ID: 23444125
[TBL] [Abstract][Full Text] [Related]
20. Curcumin has immunomodulatory effects on RANKL-stimulated osteoclastogenesis in vitro and titanium nanoparticle-induced bone loss in vivo.
Yang C; Zhu K; Yuan X; Zhang X; Qian Y; Cheng T
J Cell Mol Med; 2020 Jan; 24(2):1553-1567. PubMed ID: 31845532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
